New HampshireNew Hampshire Medicaid would cover medically useful biomarker tests
New Hampshire Medicaid would cover biomarker tests that help guide care when they are medically necessary and supported by medical or scientific evidence.
What it does
New Hampshire Medicaid would cover medically necessary biomarker tests that help diagnose, treat, manage, or monitor a condition when medical or scientific evidence supports their usefulness.
If the required budget funding is included, Medicaid plans would have to limit care disruptions, decide urgent review requests within 72 hours and other requests within 14 days, and offer an online way to seek exceptions.
Argument forIf coverage takes effect, patients could get tests that help guide care while reducing the need for repeat biopsies or samples.
Argument againstIf the funding condition is met, plans could need extra staff time to meet review deadlines and handle online requests for coverage exceptions.
More detail
New Hampshire Medicaid would cover biomarker tests it finds medically necessary and useful for care. The tests analyze a patient's tissue, blood, or other samples for biological markers. The test must help diagnose, treat, manage, or monitor a disease or condition. Medical or scientific evidence must show that the test provides useful information, such as FDA information, Medicare coverage decisions, or recognized medical guidelines. The act would take effect July 1, 2027.
The state Medicaid plan and certain contracted plans would have to limit care disruptions, meet review deadlines, and provide an online way to request coverage exceptions. These requirements cover the state Medicaid plan, contracted plans that bear financial risk, enrollees, and participating providers. The RSA 167:4-g provisions apply only if the operating budget for the two-year period ending June 30, 2029 includes sufficient funding. The health department must submit any needed Medicaid plan amendment to federal officials. The act would take effect July 1, 2027. The RSA 167:4-g provisions would take effect only if the required funding is included in the operating budget for the period ending June 30, 2029.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Oct 19Interim Study Report: Not Recommended for Future Legislation 10/15/2026 (Vote 11-0; )Latest
- Oct 1Executive Session: 10/14/2026 10:00 am GP 229
- Aug 21Subcommittee Work Session: 09/09/2026 10:00 am GP 229
- May 14Refer for Interim Study: MA VV 05/14/2026 HJ 13 P. 9
- May 1Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 8
- Apr 22Subcommittee Work Session: 04/28/2026 10:00 am GP 229
- Apr 22Executive Session: 04/29/2026 10:00 am GP 229
- Apr 16Subcommittee Work Session: 04/22/2026 10:00 am GP 229
- Apr 1Subcommittee Work Session: 04/08/2026 10:00 am GP 229
- Mar 24Public Hearing: 04/01/2026 11:00 am GP 229
- Mar 16Introduced (in recess of) 03/12/2026 and referred to Commerce and Consumer Affairs HJ 8 P. 114Minor
- Mar 12Ought to Pass: MA, VV; OT3rdg; 03/12/2026; SJ 6Passed Senate
- Mar 5Committee Report: Ought to Pass, 03/12/2026; Vote 7-0; CC; SC 9Minor
- Feb 19Ought to Pass with Amendment #2026-0689s, MA, VV; Refer to Finance Rule 4-5; 02/19/2026; SJ 4Minor
- Feb 19Committee Amendment # 2026-0689s, AA, VV; 02/19/2026; SJ 4
- Feb 12Committee Report: Ought to Pass with Amendment # 2026-0689s, 02/19/2026; Vote 5-0; CC; SC 6Minor
- Jan 22Hearing: 01/28/2026, Room 100, SH, 09:00 am; SC 3
- 2025
- Nov 25Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1Introduced
Healthcare